Former Euro PR head joins GolinHarris

Share this article:
Former Euro RSCG Life PR head David Catlett has resurfaced as head of GolinHarris’ New York healthcare practice.

Catlett, who joined Euro RSCG Life PR as president from Ketchum last year, becomes EVP for the Chicago-based firm, charged with growing the company’s healthcare practice on the East Coast. He reports to managing director Jennifer Cohan.

Despite its Midwestern base, GolinHarris has amassed a  roster of pharma clients including  Bristol-Myers Squibb; GlaxoSmithKline Consumer Healthcare; Ortho McNeil Neurologics; Shire; and Cord Blood Registry.

Catlett left Euro RSCG Life PR, the company’s product PR practice, in April, around the time the network reorganized under an executive committee following the departure of CEO Jim Metropoulos. In May, the agency spun off its corporate PR practice, Russo Partners, in a buyout, maintaining a referral relationship with the firm.

Share this article:
You must be a registered member of MMM to post a comment.

Email Newsletters

More in News

Five things for pharma marketers to know: Tuesday, September 2

Five things for pharma marketers to know: Tuesday, ...

Sanofi and Regeneron unveil Phase-III results of their PCSK9; Merck will present data on its anti-PD-1 at the end of this month; WSJ op/ed suggests US should lead fight against ...

Five things for Pharma Marketers to know: Friday, August 29

Five things for Pharma Marketers to know: Friday, ...

Takeda closes out a good-news, bad-news kind of week, AstraZeneca adds a new clinical trial for its experimental PD-1, and researchers link a funeral to the Ebola outbreak.

Amgen sends PCSK9 to FDA

Amgen sends PCSK9 to FDA

Evolocumab holds the FDA's first filed biologics license application for the class.